● Single award · contract
Advanced Development of Nitazoxanide, Administered Alone or in Combination with Oseltamivir, for Treatment of…
A single federal award, with both ends of the trail linked.
$70.7M
total award value
2013
action date
34 mo
period
HHSO100201300004C
PIID
Description
Igf::ot::igf Advanced Development of Nitazoxanide, Administered Alone or in Combination with Oseltamivir, for Treatment of Acute Uncomplicated Influenza Virus Infection in Adults and Pediatric Patients at Least 12 Years of Age
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceFlorida →
CategoryNAICS 325412PSC AN11
Competed?Not recorded✓ from source
Total (exact)$70,748,205
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.